Home > > > > > Report Detail

Investigation Report on China Adefovir Market, 2010-2019

Publisher Name :
Date: 02-Jul-2015
No. of pages: 35

In Mar. 2015, WHO issued Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection, indicating that 2 billion people around the world had or are having HBV infection and that about 240 million people are infected with chronic hepatitis B virus (HBV), among which 0.65 million die of hepatitis Brelated diseases. Hepatitis B surface antigen (HBsAg ) rate among people aged below 60 has fallen from 9.75% a decade ago to 7.18% now. However, since China has a large population base, the number of people infected with chronic HBV is calculated to be over 90 million and the number of chronic hepatitis B (CHB) patients is 20 million. Hence, the severe status of diagnosis and treatment of CHB. So far, chronic and viral hepatitis B has become one of the major threats to human health and CHB has already become the ninth leading cause of death.

Nucleotide analog, the leading antiviral product for the treatment of CHB, has such main varieties as entecavir, adefovir dipivoxil, lamivudine, telbivudine, emtricitabine and tenofovir disoproxil in the clinic.

In 2002, GlaxoSmithKline (GSK) acquired the franchise rights to market adefovir dipivoxil, the antihepatitis B drug of Gilead Sciences, Inc. in mainland China, Japan, Korea and Taiwan under the trade name of Hepsera. In 2013, the global sales value of Hepsera was down by 23.81%. In 2005, adefovir dipivoxil made by GSK was first approved to enter China under the trade name of Hepsera.

Adefovir develops fast after entering China, annual sales value rising from about CNY 10 million in 2005 to CNY 400 million in 2013 and CAGR reaching nearly 60% during the period of 20052014. GlaxoSmithKline (Tianjin) Co., Ltd, United Laboratories, Fujian Cosunter Pharmaceutical Co., Ltd and Chia Tai Tianqing Pharmaceutical Group Co., Ltd occupy the majority of the Chinese market, among which GlaxoSmithKline (Tianjin) Co., Ltd had the largest market share of about 43% for sales value in 2014.

With the large amounts of hepatitis B patients in China, the market size of adefovir is expected to keep growing in the next few years.

Readers can get at least the following information from this report:


  • market size of adefovir in China

  • competitive landscape of adefovir in Chinese market

  • price of adefovir made by different enterprises in China

  • market outlook of adefovir in China


The author suggests the following groups of people purchase this report:


  • manufacturers of antihepatitis drugs

  • investors/ research institutions interested in Chinese medicine market

  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Investigation Report on China Adefovir Market, 2010-2019

Table of Contents

1 Related Concepts of Adefovir
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Adefovir in China
2.1 Patent and Approval Status of Adefovir in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Adefovir in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Adefovir in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Adefovir in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Adefovir in Chinese Hospitals in 2014
6.1 YSY (Shanghai) Pharmaceutical Co., Ltd
6.2 TIPR Pharmaceutical Responsible Co., Ltd (Trade Name: Daiding)
6.3 Qilu Pharmaceutical Co., Ltd (Trade Name: Yilaifen)
6.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd (Trade Name: Mingzheng)
6.5 United Laboratories (Trade Name: Adixian)
6.6 Fujian Cosunter Pharmaceutical Co., Ltd (Trade Name: Aganding)
6.7 GlaxoSmithKline (Tianjin) Co., Ltd (Trade Name: Hepsera)

7 Major Manufacturers of Adefovir in Chinese Market, 2010-2014
7.1 Chia Tai Tianqing Pharmaceutical Group Co., Ltd
7.2 TIPR Pharmaceutical Responsible Co., Ltd
7.3 United Laboratories
7.4 Fujian Cosunter Pharmaceutical Co., Ltd
7.5 GlaxoSmithKline (Tianjin) Co., Ltd

8 Market Outlook of Adefovir in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

List of Charts

Chart Patent Status of Adefovir in China
Chart Approval Information of Adefovir in China
Chart Sales Status of Adefovir in China
Chart Sales Value of Adefovir in China, 2010-2014
Chart Sales Value of Adefovir in Some Regions in China, 2010-2014
Chart Sales Volume of Adefovir in China, 2010-2014
Chart Market Share of TOP3 Manufacturers of Adefovir for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Adefovir Made by GlaxoSmithKline (Tianjin)in China, 2010-2014
Chart Sales Value and Market Share of Adefovir Made by Chia Tai Tianqing in China, 2010-2014
Chart Sales Value and Market Share of Adefovir Made by TIPR in China, 2010-2014
Chart Sales Value and Market Share of Adefovir Tablets in China, 2010-2014
Chart Sales Value and Market Share of Adefovir Capsules in China, 2010-2014
Chart Price of Adefovir Made by YSY (Shanghai) Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Adefovir Made by TIPR Pharmaceutical Responsible Co., Ltd in Some Chinese Cities in 2014
Chart Price of Adefovir Made by Qilu Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Adefovir Made by Chia Tai Tianqing Pharmaceutical Group Co., Ltd in Some Chinese Cities in 2014
Chart Price of Adefovir Made by United Laboratories in Some Chinese Cities in 2014
Chart Price of Adefovir Made by Fujian Cosunter Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Adefovir Made by GlaxoSmithKline (Tianjin) Co., Ltd in Some Chinese Cities in 2014

  • Global Hepatitis A Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 89
    According to our LPI (LP Information) latest study, the global Hepatitis A Vaccine market size was valued at US$ 690.5 million in 2023. With growing demand in downstream market, the Hepatitis A Vaccine is forecast to a readjusted size of US$ 810.9 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Hepatitis A Vaccine market. Hepatitis A Vaccine are expected to show stable growth in the future market. However, produc......
  • Global Human Hepatitis B Immunoglobulin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 127
    Market Overview of Global Human Hepatitis B Immunoglobulin market: According to our latest research, the global Human Hepatitis B Immunoglobulin market looks promising in the next 5 years. As of 2022, the global Human Hepatitis B Immunoglobulin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......
  • Global Hepatitis A Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 85
    According to our (Global Info Research) latest study, the global Hepatitis A Vaccine market size was valued at USD 726.3 million in 2023 and is forecast to a readjusted size of USD 842.5 million by 2030 with a CAGR of 2.1% during review period. Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currentl......
  • Global Hepatitis A Vaccine Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117
    Report Overview: Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 ye......
  • Global Thymosin a1 Professional Survey Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 103
    Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......
  • Global Thymosin a1 Market Research Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 136
    Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......
  • Global Hepatitis B Immune Globulin Market Research Report 2023
    Published: 06-Nov-2023        Price: US 2900 Onwards        Pages: 85
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hepatitis B Immune Globulin market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - ADMA Biologics - Bio Products Laboratory - Grifols - Biotest AG - CSL Behring - FFF Enterprises - Cleveland Clinic Seg......
  • Global Sofosbuvir Market Research Report 2023
    Published: 31-Oct-2023        Price: US 2900 Onwards        Pages: 94
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sofosbuvir market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Teva Pharmaceutical Industries Ltd - DONG BANG FUTURE TECH & LIFE CO., LTD - Beaukev Pharma International Pvt.Ltd - DEAFARMA - Tecoland - Anhui HaiKang Pha......
  • Global Hepatitis A Vaccine Market Insights, Forecast to 2029
    Published: 22-Sep-2023        Price: US 4900 Onwards        Pages: 97
    Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs